Correlation Between Pasithea Therapeutics and Celldex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and Celldex Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Celldex Therapeutics.

Diversification Opportunities for Pasithea Therapeutics and Celldex Therapeutics

-0.4

Correlation Coefficient

Pasithea Therapeutics  Celldex Therapeutics

Very good diversification

The 3 months correlation between Pasithea and Celldex is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Celldex Therapeutics go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Celldex Therapeutics

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 7.38 times more return on investment than Celldex Therapeutics. However, Pasithea Therapeutics is 7.38 times more volatile than Celldex Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.13 per unit of risk. If you would invest  3.93  in Pasithea Therapeutics Corp on September 29, 2024 and sell it today you would lose (1.74) from holding Pasithea Therapeutics Corp or give up 44.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	47.62%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  Celldex Therapeutics

Pasithea Therapeutics

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unsteady basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Celldex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Pasithea Therapeutics and Celldex Therapeutics

The main advantage of trading using opposite Pasithea Therapeutics and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.

The idea behind Pasithea Therapeutics Corp and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.